Limits and patterns of cytomegalovirus genomic diversity in humans

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 30, 2015, Pages E4120-E4128

  Renzette, Nicholas ^a   Pokalyuk, Cornelia ^b,c   Gibson, Laura ^a,d   Bhattacharjee, Bornali ^a   Schleiss, Mark R ^e   Hamprecht, Klaus ^f   Yamamoto, Aparecida Y ^g   Mussi Pinhata, Marisa M ^g   Britt, William J ^h   Jensen, Jeffrey D ^c,i   Kowalik, Timothy F ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b GOETHE UNIVERSITY   (Germany)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h University of Alabama at Birmingham   (United States)

ⁱ EPFL   (Switzerland)

Author keywords

Congenital CMV; Evolution; HCMV; Human cytomegalovirus; Virology

Indexed keywords

GLYCOPROTEIN; HOST FACTOR; REGULATOR PROTEIN;

ADULT; ARTICLE; BACKGROUND SELECTION; CLINICAL ARTICLE; CONGENITAL INFECTION; CONSENSUS SEQUENCE; CYTOMEGALOVIRUS INFECTION; DNA POLYMORPHISM; DNA REPLICATION; EFFECTIVE POPULATION SIZE; GENE LOCUS; GENETIC CONSERVATION; GENETIC DISTANCE; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE EVASION; INFANT; MIXED INFECTION; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PURIFYING SELECTION; QUANTITATIVE ANALYSIS; REINFECTION; SELECTIVE SWEEP; SINGLE NUCLEOTIDE POLYMORPHISM; URINALYSIS; VIRAL GENETICS; VIRUS GENOME; CLUSTER ANALYSIS; CYTOMEGALOVIRUS; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; GENETICS; GENOMICS; ISOLATION AND PURIFICATION; MOLECULAR EVOLUTION; MUTATION; NEWBORN; VIROLOGY; VIRUS GENE;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

CLUSTER ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; GENES, VIRAL; GENETIC VARIATION; GENOME, VIRAL; GENOMICS; GLYCOPROTEINS; HUMANS; INFANT; INFANT, NEWBORN; MUTATION; POLYMORPHISM, GENETIC; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84938150487     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1501880112     Document Type: Article

References (92)

1. Alford CA, Stagno S, Pass RF, Britt WJ (1990) Congenital and perinatal cytomegalovirus infections. Rev Infect Dis 12(Suppl 7):S745-S753.
2. Cannon MJ (2009) Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 46(Suppl 4):S6-S10.
3. Balfour HH, Jr (1979) Cytomegalovirus: The troll of transplantation. Arch Intern Med 139(3):279-280.
4. Lurain NS, Chou S (2010) Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev 23(4):689-712.
5. Fouts AE, et al. (2014) Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109. Proc Natl Acad Sci USA 111(22):8209-8214.
6. Renzette N, Gibson L, Jensen JD, Kowalik TF (2014) Human cytomegalovirus intrahost evolution-a new avenue for understanding and controlling herpesvirus infections. Curr Opin Virol 8:109-115.
7. Bradley AJ, et al. (2008) Genotypic analysis of two hypervariable human cytomegalovirus genes. J Med Virol 80(9):1615-1623.
8. Cunningham C, et al. (2010) Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J Gen Virol 91(Pt 3):605-615.
9. McGeoch DJ, Rixon FJ, Davison AJ (2006) Topics in herpesvirus genomics and evolution. Virus Res 117(1):90-104.
10. Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF (2011) Extensive genomewide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog 7(5):e1001344.
11. Renzette N, et al. (2013) Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection. PLoS Genet 9(9):e1003735.
12. Huang ES, Huong SM, Tegtmeier GE, Alford C (1980) Cytomegalovirus: Genetic variation of viral genomes. Ann N Y Acad Sci 354:332-346.
13. Bradley AJ, et al. (2009) High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169. J Gen Virol 90(Pt 10):2375-2380.
14. Meyer-König U, Ebert K, Schrage B, Pollak S, Hufert FT (1998) Simultaneous infection of healthy people with multiple human cytomegalovirus strains. Lancet 352(9136):1280-1281.
15. Coaquette A, et al. (2004) Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 39(2):155-161.
16. Bhattacharjee B, Renzette N, Kowalik TF (2012) Genetic analysis of cytomegalovirus in malignant gliomas. J Virol 86(12):6815-6824.
17. Görzer I, Guelly C, Trajanoski S, Puchhammer-Stöckl E (2010) Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time. J Virol 84(14):7195-7203.
18. Numazaki K, Ikehata M, Asanuma H, Chiba S (1998) Simultaneous infection of immunocompetent individuals with multiple cytomegalovirus strains. Lancet 352(9141):1710.
19. Ross SA, et al. (2011) Mixed infection and strain diversity in congenital cytomegalovirus infection. J Infect Dis 204(7):1003-1007.
20. Spector SA, Hirata KK, Newman TR (1984) Identification of multiple cytomegalovirus strains in homosexual men with acquired immunodeficiency syndrome. J Infect Dis 150(6):953-956.
21. Puchhammer-Stöckl E, Görzer I (2006) Cytomegalovirus and Epstein-Barr virus subtypes: The search for clinical significance. J Clin Virol 36(4):239-248.
22. Pang X, Humar A, Preiksaitis JK (2008) Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a realtime PCR assay. J Clin Microbiol 46(12):4004-4010.
23. Sowmya P, Madhavan HN (2009) Analysis of mixed infections by multiple genotypes of human cytomegalovirus in immunocompromised patients. J Med Virol 81(5):861-869.
24. Leach CT, et al. (1994) A longitudinal study of cytomegalovirus infection in human immunodeficiency virus type 1-seropositive homosexual men: Molecular epidemiology and association with disease progression. J Infect Dis 170(2):293-298.
25. Frange P, et al. (2013) Temporal and spatial compartmentalization of drug-resistant cytomegalovirus (CMV) in a child with CMV meningoencephalitis: Implications for sampling in molecular diagnosis. J Clin Microbiol 51(12):4266-4269.
26. Hamprecht K, et al. (2003) Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: Pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain. J Infect Dis 187(1):139-143.
27. Zhou M, Yu Q, Wechsler A, Ryckman BJ (2013) Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope. J Virol 87(17):9680-9690.
28. Meyer-König U, et al. (1998) Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 55(1):75-81.
29. Zhang YJ, et al. (2012) Global assessment of genomic regions required for growth in Mycobacterium tuberculosis. PLoS Pathog 8(9):e1002946.
30. Sun ZR, et al. (2006) Genetic variability of human cytomegalovirus UL132 gene in strains from infected infants. Microbiol Immunol 50(10):773-779.
31. Jones TR, Sun L (1997) Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J Virol 71(4):2970-2979.
32. Ananda G, Chiaromonte F, Makova KD (2011) A genome-wide view of mutation rate co-variation using multivariate analyses. Genome Biol 12(3):R27.
33. Gao LZ, Xu H (2008) Comparisons of mutation rate variation at genome-wide microsatellites: Evolutionary insights from two cultivated rice and their wild relatives. BMC Evol Biol 8:11.
34. Lynch M, et al. (2008) A genome-wide view of the spectrum of spontaneous mutations in yeast. Proc Natl Acad Sci USA 105(27):9272-9277.
35. Lynch M (2010) Rate, molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci USA 107(3):961-968.
36. Conrad DF, et al.; 1000 Genomes Project (2011) Variation in genome-wide mutation rates within and between human families. Nat Genet 43(7):712-714.
37. Sanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R (2010) Viral mutation rates. J Virol 84(19):9733-9748.
38. Drake JW, Hwang CB (2005) On the mutation rate of herpes simplex virus type 1. Genetics 170(2):969-970.
39. Cheng TP, Valentine MC, Gao J, Pingel JT, Yokoyama WM (2010) Stability of murine cytomegalovirus genome after in vitro and in vivo passage. J Virol 84(5):2623-2628.
40. McVean GAT, et al. (2004) The fine-scale structure of recombination rate variation in the human genome. Science 304(5670):581-584.
41. Chan AH, Jenkins PA, Song YS (2012) Genome-wide fine-scale recombination rate variation in Drosophila melanogaster. PLoS Genet 8(12):e1003090.
42. Begun DJ, Aquadro CF (1992) Levels of naturally occurring DNA polymorphism correlate with recombination rates in D. melanogaster. Nature 356(6369):519-520.
43. Smith JM, Haigh J (1974) The hitch-hiking effect of a favourable gene. Genet Res 23(1):23-35.
44. Charlesworth B, Morgan MT, Charlesworth D (1993) The effect of deleterious mutations on neutral molecular variation. Genetics 134(4):1289-1303.
45. Stephan W (2010) Genetic hitchhiking versus background selection: The controversy and its implications. Philos Trans R Soc Lond B Biol Sci 365(1544):1245-1253.
46. Jombart T, Devillard S, Balloux F (2010) Discriminant analysis of principal components: A new method for the analysis of genetically structured populations. BMC Genet 11:94.
47. Jombart T (2008) adegenet: A R package for the multivariate analysis of genetic markers. Bioinformatics 24(11):1403-1405.
48. Rands CM, Meader S, Ponting CP, Lunter G (2014) 8.2% of the Human genome is constrained: Variation in rates of turnover across functional element classes in the human lineage. PLoS Genet 10(7):e1004525.
49. Snoeck J, Fellay J, Bartha I, Douek DC, Telenti A (2011) Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints. Retrovirology 8:87.
50. Jia F, Lo N, Ho SYW (2014) The impact of modelling rate heterogeneity among sites on phylogenetic estimates of intraspecific evolutionary rates and timescales. PLoS ONE 9(5):e95722.
51. Zhou Y, Ushijima H, Frey TK (2007) Genomic analysis of diverse rubella virus genotypes. J Gen Virol 88(Pt 3):932-941.
52. Hraber PT, Fischer W, Bruno WJ, Leitner T, Kuiken C (2006) Comparative analysis of hepatitis C virus phylogenies from coding and non-coding regions: The 5' untranslated region (UTR) fails to classify subtypes. Virol J 3(1):103.
53. Goldner T, et al. (2011) The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase. J Virol 85(20):10884-10893.
54. Puchhammer-Stöckl E, Görzer I (2011) Human cytomegalovirus: An enormous variety of strains and their possible clinical significance in the human host. Future Virol 6(2):259-271.
55. Datta A, Jinks-Robertson S (1995) Association of increased spontaneous mutation rates with high levels of transcription in yeast. Science 268(5217):1616-1619.
56. Park C, Qian W, Zhang J (2012) Genomic evidence for elevated mutation rates in highly expressed genes. EMBO Rep 13(12):1123-1129.
57. Liang Y, et al. (2013) Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency. Sci Transl Med 5(167):167ra165.
58. Hill JM, et al. (2014) Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes. Sci Transl Med 6(265):265ra169.
59. Burkala E, et al. (2007) Secondary structures as predictors of mutation potential in the lacZ gene of Escherichia coli. Microbiology 153(Pt 7):2180-2189.
60. Kaplan NL, Hudson RR, Langley CH (1989) The "hitchhiking effect" revisited. Genetics 123(4):887-899.
61. Kim Y, Stephan W (2000) Joint effects of genetic hitchhiking and background selection on neutral variation. Genetics 155(3):1415-1427.
62. Corbett-Detig RB, Hartl DL, Sackton TB (2015) Natural selection constrains neutral diversity across a wide range of species. PLoS Biol 13(4):e1002112.
63. Gibson L, et al. (2007) Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants. J Infect Dis 195(12):1789-1798.
64. Gibson L, et al. (2004) Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. J Immunol 172(4):2256-2264.
65. Gibson L, et al. (2015) Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection. J Clin Immunol 35(3):289-301.
66. Marchant A, et al. (2003) Mature CD8 (+) T lymphocyte response to viral infection during fetal life. J Clin Invest 111(11):1747-1755.
67. Sanchez-Merino V, Nie S, Luzuriaga K (2005) HIV-1-specific CD8+ T cell responses and viral evolution in women and infants. J Immunol 175(10):6976-6986.
68. Sanchez-Merino V, Farrow MA, Brewster F, Somasundaran M, Luzuriaga K (2008) Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness. J Infect Dis 197(2):300-308.
69. Griffiths P, et al. (2013) Desirability and feasibility of a vaccine against cytomegalovirus. Vaccine 31(Suppl 2):B197-B203.
70. Ross SA, et al. (2010) Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 201(3):386-389.
71. Britt W (2015) Controversies in the natural history of congenital human cytomegalovirus infection: The paradox of infection and disease in offspring of women with immunity prior to pregnancy. Med Microbiol Immunol (Berl) 204(3):263-271.
72. Wang C, Zhang X, Bialek S, Cannon MJ (2011) Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 52(2):e11-e13.
73. Chee MS, Lawrence GL, Barrell BG (1989) Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. J Gen Virol 70(Pt 5):1151-1160.
74. Gawel D, Pham PT, Fijalkowska IJ, Jonczyk P, Schaaper RM (2008) Role of accessory DNA polymerases in DNA replication in Escherichia coli: Analysis of the dnaX36 mutator mutant. J Bacteriol 190(5):1730-1742.
75. Longley MJ, Nguyen D, Kunkel TA, Copeland WC (2001) The fidelity of human DNA polymerase γ with and without exonucleolytic proofreading and the p55 accessory subunit. J Biol Chem 276(42):38555-38562.
76. Appleton BA, et al. (2006) Crystal structure of the cytomegalovirus DNA polymerase subunit UL44 in complex with the C terminus from the catalytic subunit: Differences in structure and function relative to unliganded UL44. J Biol Chem 281(8):5224-5232.
77. Appleton BA, Loregian A, Filman DJ, Coen DM, Hogle JM (2004) The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer. Mol Cell 15(2):233-244.
78. e X, et al. (2011) An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus. PLoS Pathog 7(5):e1001342.
79. Xiaofei E, Kowalik TF (2014) The DNA damage response induced by infection with human cytomegalovirus and other viruses. Viruses 6(5):2155-2185.
80. Sinzger C, et al. (2008) Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 89(Pt 2):359-368.
81. Ryckman BJ, Chase MC, Johnson DC (2008) HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: Evidence for cell type-specific receptors. Proc Natl Acad Sci USA 105(37):14118-14123.
82. Wang D, Shenk T (2005) Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci USA 102(50):18153-18158.
83. Sinzger C, Digel M, Jahn G (2008) Cytomegalovirus cell tropism. Human Cytomegalovirus, Current Topics in Microbiology and Immunology, eds Shenk T, Stinski M (Springer, Berlin), Vol 325, pp 63-83.
84. Janeway C, Travers P, Walport M, Shlomchik M (2001) Immunobiology: The Immune System in Health and Disease (Garland Science, New York), 5th Ed.
85. Sylwester AW, et al. (2005) Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202(5):673-685.
86. Poole E, Wills M, Sinclair J (2014) Human cytomegalovirus latency: Targeting differences in the latently infected cell with a view to clearing latent infection. New J Sci 2014:313761.
87. Emery VC, Cope AV, Bowen EF, Gor D, Griffiths PD (1999) The dynamics of human cytomegalovirus replication in vivo. J Exp Med 190(2):177-182.
88. R Core Team (2014) R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna). Available at www.R-project.org/.
89. Tibshirani R, Walther G, Hastie T (2001) Estimating the number of clusters in a data set via the gap statistic. J R Stat Soc Series B Stat Methodol 63(2):411-423.
90. Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K (2015) cluster: Cluster Analysis Basics and Extensions R package version 2.0.2.
91. Weir BS, Cockerham CC (1984) Estimating F-statistics for the analysis of population structure. Evolution 38(6):1358-1370.
92. Underwood MA, Gilbert WM, Sherman MP (2005) Amniotic fluid: Not just fetal urine anymore. J Perinatol 25(5):341-348.